Covered recipient · General Payments record
STEPHANIE B WALSH
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$4,239.47
- Reported across 261 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $552.60 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $330.38 | 19 |
| Amgen Inc. | $57.42 | 3 |
| Regeneron Healthcare Solutions, Inc. | $53.01 | 2 |
| Kerecis Limited | $38.67 | 1 |
| Lilly USA, LLC | $21.70 | 1 |
| Verrica Pharmaceuticals Inc. | $18.98 | 1 |
| Janssen Biotech, Inc. | $17.20 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.41 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302627 | CMS |
| ABBVIE INC. | $14.00 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302629 | CMS |
| ABBVIE INC. | $20.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302631 | CMS |
| ABBVIE INC. | $28.19 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302633 | CMS |
| ABBVIE INC. | $15.31 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302635 | CMS |
| ABBVIE INC. | $13.07 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302637 | CMS |
| ABBVIE INC. | $16.41 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302639 | CMS |
| ABBVIE INC. | $19.76 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302641 | CMS |
| ABBVIE INC. | $14.07 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302643 | CMS |
| ABBVIE INC. | $11.33 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302645 | CMS |
| ABBVIE INC. | $19.50 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302647 | CMS |
| ABBVIE INC. | $14.89 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302649 | CMS |
| ABBVIE INC. | $20.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302651 | CMS |
| ABBVIE INC. | $21.30 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302653 | CMS |
| ABBVIE INC. | $14.63 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302655 | CMS |
| ABBVIE INC. | $16.35 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302657 | CMS |
| ABBVIE INC. | $15.44 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302659 | CMS |
| ABBVIE INC. | $18.12 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302661 | CMS |
| ABBVIE INC. | $16.99 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106302663 | CMS |
| Amgen Inc. | $19.59 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117712777 | CMS |
| Amgen Inc. | $18.21 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117712779 | CMS |
| Amgen Inc. | $19.62 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117712781 | CMS |
| Janssen Biotech, Inc. | $17.20 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078255829 | CMS |
| Kerecis Limited | $38.67 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120099214 | CMS |
| Lilly USA, LLC | $21.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349892 | CMS |
| Novartis Pharmaceuticals Corporation | $15.24 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087386892 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114243976 | CMS |
| Regeneron Healthcare Solutions, Inc. | $27.74 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114243982 | CMS |
| Verrica Pharmaceuticals Inc. | $18.98 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118387978 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.